SunTrust Stock Rating Lowered by UBS AG (STI)

SunTrust (NYSE: STI) was downgraded by stock analysts at UBS AG from a “buy” rating to a “neutral” rating in a report issued on Friday, TheFlyOnTheWall.com reports. The analysts noted that the move was a valuation call.

Other equities research analysts have also recently issued reports about the stock. Analysts at TheStreet reiterated a “buy” rating on shares of SunTrust in a research note to investors on Tuesday, June 4th. Separately, analysts at Zacks reiterated a “neutral” rating on shares of SunTrust in a research note to investors on Monday, June 3rd. They now have a $33.50 price target on the stock. Finally, analysts at Standpoint Research initiated coverage on shares of SunTrust in a research note to investors on Wednesday, May 29th. They set a “buy” rating and a $44.00 price target on the stock.

Two analysts have rated the stock with a sell rating, sixteen have given a hold rating and ten have given a buy rating to the company. The company currently has an average rating of “Hold” and an average target price of $31.48.

SunTrust (NYSE: STI) traded down 2.69% on Friday, hitting $31.09. SunTrust has a 1-year low of $21.72 and a 1-year high of $32.84. The stock’s 50-day moving average is currently $31.1. The company has a market cap of $16.654 billion and a price-to-earnings ratio of 8.50.

SunTrust (NYSE: STI) last issued its quarterly earnings data on Friday, April 19th. The company reported $0.63 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.62 by $0.01. The company had revenue of $2.11 billion for the quarter, compared to the consensus estimate of $2.25 billion. During the same quarter last year, the company posted $0.46 earnings per share. SunTrust’s revenue was down 4.8% compared to the same quarter last year. Analysts expect that SunTrust will post $2.71 EPS for the current fiscal year.

SunTrust Banks, Inc. (NYSE: STI) is a commercial banking organization.

The Fly On The Wall

Latest News

Allianz Asset Management GmbH Sells 233,623 Shares of IAMGOLD Corp
Allianz Asset Management GmbH Sells 233,623 Shares of IAMGOLD Corp
Alps Advisors Inc. Has $4.40 Million Holdings in JPMorgan Chase & Co.
Alps Advisors Inc. Has $4.40 Million Holdings in JPMorgan Chase & Co.
Amalgamated Bank Has $2.40 Million Stake in Nektar Therapeutics
Amalgamated Bank Has $2.40 Million Stake in Nektar Therapeutics
Amalgamated Bank Has $2.30 Million Stake in Kellogg
Amalgamated Bank Has $2.30 Million Stake in Kellogg
McCormick & Company  Holdings Reduced by Allianz Asset Management GmbH
McCormick & Company Holdings Reduced by Allianz Asset Management GmbH
Allianz Asset Management GmbH Has $3.93 Million Holdings in ImmunoGen, Inc.
Allianz Asset Management GmbH Has $3.93 Million Holdings in ImmunoGen, Inc.


© 2006-2018 Ticker Report. Google+.